How should ketamine‑induced laryngospasm be managed when no paralytic agents are available?

Management of Ketamine-Induced Laryngospasm Without Paralytic Agents

When paralytic agents are unavailable for ketamine-induced laryngospasm, immediately apply continuous positive airway pressure with 100% oxygen, perform Larson's maneuver, and administer propofol 1–2 mg/kg IV as the primary pharmacological intervention. 1, 2

Immediate Non-Pharmacological Interventions

Step 1: Call for Help and Optimize Oxygenation

• Immediately call for assistance and ensure continuous monitoring of vital signs and oxygen saturation 1, 2
• Apply CPAP with 100% oxygen using a reservoir bag and facemask while maintaining upper airway patency with jaw thrust 1, 2
• Avoid any unnecessary airway stimulation that could worsen the laryngospasm 1, 2

Step 2: Larson's Maneuver

• Place the middle finger of each hand in the "laryngospasm notch" (located between the posterior border of the mandible and the mastoid process) 1, 2
• Apply deep pressure at this point while simultaneously performing a jaw thrust; this mechanical maneuver can terminate laryngospasm in many cases 1, 2

Pharmacological Management Without Paralytics

Primary Agent: Propofol

• Administer propofol 1–2 mg/kg IV for persistent laryngospasm or falling oxygen saturation 1, 2
• Low doses may suffice for early laryngospasm, but larger doses are required for severe laryngospasm or total cord closure 1, 2
• Propofol works by deepening anesthesia and relaxing the vocal cords without requiring neuromuscular blockade 1, 2

Alternative Routes if IV Access Unavailable

• If intravenous access is not available and the situation is deteriorating, consider intraosseous access for medication administration 1, 2
• The Difficult Airway Society guidelines note that suxamethonium can be given via intramuscular (2–4 mg/kg), intralingual (2–4 mg/kg), or intraosseous (1 mg/kg) routes when IV access is absent, though you've specified no paralytics are available 1, 2

Critical Considerations Specific to Ketamine

Ketamine's Paradoxical Role

• Ketamine itself can both cause and potentially worsen laryngospasm, particularly during airway procedures 3, 4
• The FDA label warns that ketamine does not suppress pharyngeal and laryngeal reflexes and should be avoided as a sole agent for procedures involving the pharynx, larynx, or bronchial tree 5
• Active laryngeal-pharyngeal reflexes persist with ketamine, which may contribute to laryngospasm risk 5

Hypersalivation Management

• Ketamine increases salivation, which can trigger or worsen laryngospasm 5, 4
• If ketamine is being used and an antisialagogue was not given prophylactically, this represents a missed preventive opportunity 5
• Atropine should be readily available not only for potential bradycardia but also to reduce secretions if needed 1, 2

Escalation Without Paralytics

If Propofol Fails

• Deepen anesthesia further with additional propofol rather than accepting inadequate dosing 1, 2
• Maintain CPAP and positive pressure ventilation throughout; forceful bag-mask ventilation may be necessary 1, 2
• Prepare for emergency surgical airway (cricothyrotomy or tracheostomy) if complete airway obstruction persists and oxygenation cannot be maintained 2

Monitoring for Complications

• Post-obstructive pulmonary edema occurs in >50% of laryngospasm cases with forceful inspiratory effort against a closed airway 2
• Watch for dyspnea, agitation, cough, pink frothy sputum, and falling oxygen saturations after laryngospasm resolves 2

Critical Pitfalls to Avoid

• Do not wait for spontaneous resolution; the vocal cords rarely reopen before severe hypoxia or death occurs 1, 2
• Do not use inadequate propofol doses; escalate dosing aggressively in severe cases rather than accepting partial response 1, 2
• Do not continue ketamine administration if laryngospasm develops, as ketamine may be contributing to the problem 3, 4
• Recognize that "silent inspiration" indicates complete obstruction, not improvement—this requires immediate aggressive intervention 1

Evidence Quality Note

The Difficult Airway Society guidelines 1, 2 represent the highest-quality evidence for laryngospasm management and explicitly outline the stepwise approach with propofol as the primary pharmacological agent before paralytics. While suxamethonium is their recommended next step, propofol remains the evidence-based intervention when neuromuscular blockade is unavailable. Research evidence 3, 4, 6 confirms ketamine's association with laryngospasm, supporting aggressive propofol-based management in this specific scenario.